Matches in SemOpenAlex for { <https://semopenalex.org/work/W4386439051> ?p ?o ?g. }
- W4386439051 abstract "To investigate whether letrozole pre-treatment is non-inferior to mifepristone pre-treatment, followed by misoprostol, for complete evacuation in the medical treatment of first-trimester missed miscarriage.Prospective open-label non-inferiority randomised controlled trial.A university-affiliated hospital.We recruited 294 women diagnosed with first-trimester missed miscarriage who opted for medical treatment.Participants were randomly assigned to: (i) the mifepristone group, who received 200 mg mifepristone orally followed 24-48 h later by 800 μg misoprostol vaginally; or (ii) the letrozole group, who received 10 mg letrozole orally once-a-day for 3 days, followed by 800 μg misoprostol vaginally on the third (i.e. last) day of letrozole administration.The primary outcome was the rate of complete evacuation without surgical intervention at 42 days post-treatment. Secondary outcomes included induction-to-expulsion interval, adverse effects, women's satisfaction, number of doses of misoprostol required, duration of vaginal bleeding, pain score on the day of misoprostol administration and other adverse events.The complete evacuation rates were 97.8% (95% CI 95.1%-100%) and 97.2% (95% CI 94.4%-99.9%) in the letrozole and mifepristone groups, respectively (p ≤ 0.001 for non-inferiority). The mean induction-to-tissue expulsion interval in the letrozole group was longer compared with the mifepristone group (15.4 vs 9.0 h) (p = 0.03). The letrozole group had less heavy post-treatment bleeding and an earlier return of menses. There were no statistically significant differences in the number of doses of misoprostol required, the duration of vaginal bleeding, the pain score on the day of misoprostol administration and the rate of other adverse events between the two groups. The majority of the women (91.2% and 93.9% in the letrozole and mifepristone groups, respectively) were satisfied with their treatment option.Letrozole is non-inferior to mifepristone as a pre-treatment, followed by misoprostol, for the medical treatment of first-trimester missed miscarriage." @default.
- W4386439051 created "2023-09-06" @default.
- W4386439051 creator A5002110023 @default.
- W4386439051 creator A5008098651 @default.
- W4386439051 creator A5009823475 @default.
- W4386439051 creator A5010381174 @default.
- W4386439051 creator A5011164426 @default.
- W4386439051 creator A5016768899 @default.
- W4386439051 creator A5018805094 @default.
- W4386439051 creator A5020141346 @default.
- W4386439051 creator A5029271717 @default.
- W4386439051 creator A5046044171 @default.
- W4386439051 creator A5052712156 @default.
- W4386439051 creator A5059431543 @default.
- W4386439051 creator A5066716873 @default.
- W4386439051 creator A5071928865 @default.
- W4386439051 creator A5091603525 @default.
- W4386439051 date "2023-09-05" @default.
- W4386439051 modified "2023-10-02" @default.
- W4386439051 title "Comparing letrozole and mifepristone pre‐treatment in medical management of first trimester missed miscarriage: a prospective open‐label non‐inferiority randomised controlled trial" @default.
- W4386439051 cites W1969733684 @default.
- W4386439051 cites W1982611065 @default.
- W4386439051 cites W2004047130 @default.
- W4386439051 cites W2018841225 @default.
- W4386439051 cites W2030050870 @default.
- W4386439051 cites W2038236886 @default.
- W4386439051 cites W2059661950 @default.
- W4386439051 cites W2061374028 @default.
- W4386439051 cites W2077672824 @default.
- W4386439051 cites W2105071338 @default.
- W4386439051 cites W2115221003 @default.
- W4386439051 cites W2137542469 @default.
- W4386439051 cites W2148453156 @default.
- W4386439051 cites W2163114814 @default.
- W4386439051 cites W2199492467 @default.
- W4386439051 cites W2346325921 @default.
- W4386439051 cites W2607039050 @default.
- W4386439051 cites W2785225802 @default.
- W4386439051 cites W2806325823 @default.
- W4386439051 cites W3081386294 @default.
- W4386439051 cites W3119713954 @default.
- W4386439051 cites W4210803753 @default.
- W4386439051 cites W4239309506 @default.
- W4386439051 doi "https://doi.org/10.1111/1471-0528.17646" @default.
- W4386439051 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/37667661" @default.
- W4386439051 hasPublicationYear "2023" @default.
- W4386439051 type Work @default.
- W4386439051 citedByCount "0" @default.
- W4386439051 crossrefType "journal-article" @default.
- W4386439051 hasAuthorship W4386439051A5002110023 @default.
- W4386439051 hasAuthorship W4386439051A5008098651 @default.
- W4386439051 hasAuthorship W4386439051A5009823475 @default.
- W4386439051 hasAuthorship W4386439051A5010381174 @default.
- W4386439051 hasAuthorship W4386439051A5011164426 @default.
- W4386439051 hasAuthorship W4386439051A5016768899 @default.
- W4386439051 hasAuthorship W4386439051A5018805094 @default.
- W4386439051 hasAuthorship W4386439051A5020141346 @default.
- W4386439051 hasAuthorship W4386439051A5029271717 @default.
- W4386439051 hasAuthorship W4386439051A5046044171 @default.
- W4386439051 hasAuthorship W4386439051A5052712156 @default.
- W4386439051 hasAuthorship W4386439051A5059431543 @default.
- W4386439051 hasAuthorship W4386439051A5066716873 @default.
- W4386439051 hasAuthorship W4386439051A5071928865 @default.
- W4386439051 hasAuthorship W4386439051A5091603525 @default.
- W4386439051 hasBestOaLocation W43864390511 @default.
- W4386439051 hasConcept C121608353 @default.
- W4386439051 hasConcept C126322002 @default.
- W4386439051 hasConcept C131872663 @default.
- W4386439051 hasConcept C141071460 @default.
- W4386439051 hasConcept C168563851 @default.
- W4386439051 hasConcept C197934379 @default.
- W4386439051 hasConcept C2777176818 @default.
- W4386439051 hasConcept C2778642596 @default.
- W4386439051 hasConcept C2778812593 @default.
- W4386439051 hasConcept C2778826759 @default.
- W4386439051 hasConcept C2779199973 @default.
- W4386439051 hasConcept C2779234561 @default.
- W4386439051 hasConcept C2779245376 @default.
- W4386439051 hasConcept C2780218171 @default.
- W4386439051 hasConcept C530470458 @default.
- W4386439051 hasConcept C54355233 @default.
- W4386439051 hasConcept C71924100 @default.
- W4386439051 hasConcept C86803240 @default.
- W4386439051 hasConceptScore W4386439051C121608353 @default.
- W4386439051 hasConceptScore W4386439051C126322002 @default.
- W4386439051 hasConceptScore W4386439051C131872663 @default.
- W4386439051 hasConceptScore W4386439051C141071460 @default.
- W4386439051 hasConceptScore W4386439051C168563851 @default.
- W4386439051 hasConceptScore W4386439051C197934379 @default.
- W4386439051 hasConceptScore W4386439051C2777176818 @default.
- W4386439051 hasConceptScore W4386439051C2778642596 @default.
- W4386439051 hasConceptScore W4386439051C2778812593 @default.
- W4386439051 hasConceptScore W4386439051C2778826759 @default.
- W4386439051 hasConceptScore W4386439051C2779199973 @default.
- W4386439051 hasConceptScore W4386439051C2779234561 @default.
- W4386439051 hasConceptScore W4386439051C2779245376 @default.
- W4386439051 hasConceptScore W4386439051C2780218171 @default.
- W4386439051 hasConceptScore W4386439051C530470458 @default.
- W4386439051 hasConceptScore W4386439051C54355233 @default.
- W4386439051 hasConceptScore W4386439051C71924100 @default.